Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $1,227 - $1,351
12 Added 46.15%
38 $4,000
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $885 - $1,195
-11 Reduced 29.73%
26 $3,000
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $293 - $392
-4 Reduced 9.76%
37 $4,000
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $1,322 - $1,590
-21 Reduced 33.87%
41 $3,000
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $308 - $363
4 Added 6.9%
62 $5,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $4,051 - $5,174
58
58 $5,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ranger Investment Management, L.P. Portfolio

Follow Ranger Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranger Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ranger Investment Management, L.P. with notifications on news.